Hepatitis c virus infection among pregnant women in slovenia: Study on 31,849 samples obtained in four screening rounds during 1999, 2003, 2009 and 2013

Eurosurveillance

Volumn 20, Issue 22, 2015, Pages

  Kopilovic B ^a   Poljak, M ^b   Seme, K ^b   Klavs, I ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INFECTION RISK; PREGNANT WOMAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOVENIA; SYPHILIS; VIREMIA; BLOOD; CLASSIFICATION; GENETICS; HEPACIVIRUS; ISOLATION AND PURIFICATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PROCEDURES; SENTINEL SURVEILLANCE; VIROLOGY; YOUNG ADULT;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PREVALENCE; RNA, VIRAL; SENTINEL SURVEILLANCE; SLOVENIA; VIREMIA; YOUNG ADULT;

EID: 84932617940     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.22.21144     Document Type: Article

References (31)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333-42. http://dx.doi.org/10.1002/hep.26141 PMID:23172780
2. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271-8. http://dx.doi.org/10.7326/0003-4819156-4-201202210-00004 PMID:22351712
3. Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med. 2013;158(5 Pt 1):329-37. http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00005 PMID:23460056
4. Lazarus JV, Sperle I, Matičič M, Wiessing L. A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region. BMC Infect Dis. 2014;14(Suppl 6):S16. http://dx.doi.org/10.1186/1471-2334-14-S6-S16 PMID:25252742
5. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008;48(1):148-62. http://dx.doi.org/10.1016/j.jhep.2007.07.033 PMID:18022726
6. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill. 2008;13(21):18880. PMID:18761967
7. Duberg A, Janzon R, Back E, Ekdahl K, Blaxhult A. The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill. 2008;13(21):18882. PMID:18761966
8. Cozzolongo R, Osella AR, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V, et al.; NUTRIHEP Collaborating Group. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol. 2009;104(11):2740-6. http://dx.doi.org/10.1038/ajg.2009.428 PMID:19638964
9. Delarocque-Astagneau E, Meffre C, Dubois F, Pioche C, Le Strat Y, Roudot-Thoraval F, et al.; Hepatitis C Surveillance System Committee; Scientific Committee for the National Prevalence Survey of Hepatitis B and C Markers. The impact of the prevention programme of hepatitis C over more than a decade: the French experience. J Viral Hepat. 2010;17(6):435-43. http://dx.doi.org/10.1111/j.1365-2893.2009.01196.x PMID:19780936
10. World Health Organization (WHO). Global policy report on the prevention and control of viral hepatitis in WHO Member States. Geneva: WHO Press; 2013. p. 208
11. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39. PMID:9790221
12. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al.; Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4):1-32. PMID:22895429
13. World Health Organization (WHO). Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: WHO Press; 2014. P 122.
14. Kraigher A, Sočan M, Klavs I, Frelih T, Grilc E, Grgič Vitek M, et al., editors. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 2012. [Epidemiological surveillance of communicable diseases in Slovenia in 2012]. Ljubljana: Inštitut za varovanje zdravja; 2013. p. 107. Slovenian.
15. Seme K, Poljak M, Žužek-Resek S, Avšič-Zupanc T. High prevalence of hepatitis C virus infection in hemodialysis patients from one dialysis unit in Slovenia. Nephron. 1995;71(1):99-100. http://dx.doi.org/10.1159/000188682 PMID:8538857
16. Seme K, Poljak M, Lešničar G, Močivnik M. Dialysis unit without hepatitis C virus infection in Slovenia. Nephron. 1996;73(2):322. http://dx.doi.org/10.1159/000189064 PMID:8773368
17. Trišler Z, Seme K, Poljak M, Čelan-Lucu B, Sakoman S. Prevalence of hepatitis C and G virus infections among intravenous drug users in Slovenia and Croatia. Scand J Infect Dis. 1999;31(1):33-5. http://dx.doi.org/10.1080/00365549950161853 PMID:10381215
18. Seme K, Lunar MM, Tomažič J, Vidmar L, Karner P, Matičič M, et al. Low prevalence of hepatitis B and C infections among HIV-infected individuals in Slovenia: a nation-wide study, 1986-2008. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18(4):153-6. PMID:20043052
19. Seme K, Vrhovac M, Močilnik T, Matičič M, Lešničar G, Baklan Z, et al. Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007. J Med Virol. 2009;81(4):634-9. http://dx.doi.org/10.1002/jmv.21427 PMID:19235845
20. Klavs I, Kustec T. Drug Related Infectious Diseases. In: Drev A, ed. Report on the Drug situation 2014 of the Republic of Slovenia. Ljubljana: Inštitut za varovanje zdravja; 2014. p. 107
21. Levičnik Stezinar S, Rahne Potokar U. Presejanje krvodajalcev na označevalce okužb v Sloveniji v obdobju 1991-2010. [Screening of blood donors for markers of infection in Slovenia in the period 1991-2010]. Zdrav Vestn. 2012;81(11):257-65. Slovenian.
22. Klavs I, Poljak M. Unlinked anonymous monitoring of human immunodeficiency virus prevalence in high- and low-risk groups in Slovenia, 1993-2002. Croat Med J. 2003;44(5):545-9. PMID:14515410
23. Klavs I, Kustec T, Kastelic Z. Okužba s HIV v Sloveniji Letno poročilo 2013. [HIV infection in Slovenia Annual Report 2013]. Ljubljana: Inštitut za varovanje zdravja; 2014. p.25. Slovenian.
24. Ades AE, Parker S, Walker J, Cubitt WD, Jones R. HCV prevalence in pregnant women in the UK. Epidemiol Infect. 2000;125(2):399-405. http://dx.doi.org/10.1017/S0950268899004598 PMID:11117964
25. Urbanus AT, van Keep M, Matser AA, Rozenbaum MH, Weegink CJ, van den Hoek A, et al. Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? PLoS ONE. 2013;8(8):e70319. http://dx.doi.org/10.1371/journal.pone.0070319 PMID:23950920
26. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology. 2000;31(3):751-5. http://dx.doi.org/10.1002/hep.510310328 PMID:10706568
27. Raptopoulou-Gigi M, Orphanou E, Lalla TH, Lita A, Garifallos A. Prevalence of hepatitis C virus infection in a cohort of pregnant women in northern Greece and transmission of HCV from mother to child. Eur J Epidemiol. 2001;17(3):263-6. http://dx.doi.org/10.1023/A:1017951605272 PMID:11680545
28. Drobeniuc J, Hutin YJ, Harpaz R, Favorov M, Melnik A, Iarovoi P, et al. Prevalence of hepatitis B, D and C virus infections among children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants. Epidemiol Infect. 1999;123(3):463-7. http://dx.doi.org/10.1017/S0950268899003003 PMID:10694158
29. Costa ZB, Machado GC, Avelino MM, Gomes Filho C, Macedo Filho JV, Minuzzi AL, et al. Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis. 2009;9(116):116. http://dx.doi.org/10.1186/1471-2334-9-116 PMID:19635135
30. European Centre for Disease Prevention and Control (ECDC). Surveillance and prevention of hepatitis B and C in Europe. Stockholm: ECDC; 2010.
31. Urbanus AT, van de Laar TJW, van den Hoek A, Zuure FR, Speksnijder AGCL, Baaten GGG, et al. Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened? J Hepatol. 2011;55(6):1207-14. http://dx.doi.org/10.1016/j.jhep.2011.02.028 PMID:21703202